Acquired Fanconi syndrome secondary to monoclonal gammopathies: a case series from a single center.

[1]  P. Richardson,et al.  Kidney disease associated with plasma cell dyscrasias. , 2010, Blood.

[2]  M. Dimopoulos,et al.  Bortezomib with or without dexamethasone in primary systemic (light chain) amyloidosis. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  G. Bhagat,et al.  Light chain proximal tubulopathy. , 2009, Kidney international.

[4]  M Boccadoro,et al.  International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders , 2009, Leukemia.

[5]  M. Picken,et al.  Expanding the pathologic spectrum of immunoglobulin light chain proximal tubulopathy. , 2009, Archives of pathology & laboratory medicine.

[6]  R. Fonseca,et al.  Acquired Fanconi syndrome is an indolent disorder in the absence of overt multiple myeloma. , 2004, Blood.

[7]  G. Markowitz.  Dysproteinemia and the Kidney , 2004, Advances in anatomic pathology.

[8]  H. Izzedine,et al.  Drug-induced Fanconi's syndrome. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[9]  C. Foussard,et al.  Is there any significance for intracellular crystals in plasma cells from patients with monoclonal gammopathies? , 2001, European journal of haematology.

[10]  S. Deret,et al.  Adult Faconi Syndrome Secondary to Light Chain Gammopathy: Clinicopathologic Heterogeneity and Unnsual Features in 11 Patients , 2000, Medicine.

[11]  M. Gertz,et al.  Acquired Fanconi's syndrome associated with monoclonal gammopathies. , 1999, Hematology/oncology clinics of North America.

[12]  M. Cogné,et al.  Mutational analysis in murine models for myeloma-associated Fanconi's syndrome or cast myeloma nephropathy. , 1999, Blood.

[13]  P. Ronco,et al.  The molecular bases of plasma cell dyscrasia-related renal diseases. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[14]  F. Kametani,et al.  V-domain deposition of lambda Bence Jones protein in the renal tubular epithelial cells in a patient with the adult Fanconi syndrome with myeloma. , 1998, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[15]  A. Khamlichi,et al.  Sequences of V kappa L subgroup light chains in Fanconi's syndrome. Light chain V region gene usage restriction and peculiarities in myeloma-associated Fanconi's syndrome. , 1995, Journal of immunology.

[16]  L. Noel,et al.  Protease resistance and binding of Ig light chains in myeloma-associated tubulopathies. , 1995, Kidney international.

[17]  A. Khamlichi,et al.  Monoclonal Ig L chain and L chain V domain fragment crystallization in myeloma-associated Fanconi's syndrome. , 1993, Journal of immunology.

[18]  J. Velosa,et al.  Fanconi syndrome in adults. A manifestation of a latent form of myeloma. , 1975, The American journal of medicine.

[19]  H. Gonick,et al.  THE ADULT FANCONI SYNDROME: Observations On Etiology, Morphology, Renal Function And Mineral Metabolism In Three Patients , 1972, Medicine.

[20]  G. Fanconi.  Der nephrotisch-glykosurische Zwergwuchs mit hypophosphatämischer Rachitis1 , 1936 .